ArticleFrontiers in pharmacology2022

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study.

Jaouad Azzahhafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.